Roche Holding AG (RHHBY)

30.09 +0.26 (+0.87%) USD  |  OTCM  |  May 06, 16:09
More

Roche Cash and Short Term Investments (Quarterly): 12.51B for Dec. 31, 2023

Cash and Short Term Investments (Quarterly) Chart

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2006. Upgrade now.
Date Value
December 31, 2023 12.51B
June 30, 2023 8.350B
June 30, 2023 8.350B
December 31, 2022 10.53B
June 30, 2022 7.134B
June 30, 2022 7.134B
December 31, 2021 14.26B
June 30, 2021 8.705B
June 30, 2021 8.705B
December 31, 2020 14.12B
June 30, 2020 6.573B
June 30, 2020 6.573B
December 31, 2019 12.24B
June 30, 2019 11.44B
June 30, 2019 11.44B
December 31, 2018 13.32B
June 30, 2018 9.004B
June 30, 2018 9.004B
December 31, 2017 12.32B
June 30, 2017 7.257B
June 30, 2017 7.257B
December 31, 2016 8.950B
June 30, 2016 6.676B
June 30, 2016 6.676B
December 31, 2015 9.278B
Date Value
June 30, 2015 7.341B
June 30, 2015 7.341B
December 31, 2014 11.84B
June 30, 2014 11.53B
June 30, 2014 11.53B
December 31, 2013 13.45B
June 30, 2013 8.211B
June 30, 2013 8.211B
December 31, 2012 15.33B
June 30, 2012 9.551B
June 30, 2012 9.551B
December 31, 2011 12.00B
June 30, 2011 9.918B
June 30, 2011 9.918B
December 31, 2010 11.66B
June 30, 2010 8.274B
December 31, 2009 17.91B
June 30, 2009 17.79B
December 31, 2008 19.44B
June 30, 2008 15.38B
June 30, 2008 15.38B
December 31, 2007 21.35B
June 30, 2007 19.04B
June 30, 2007 19.04B
December 31, 2006 19.94B

Cash and Short Term Investments Definition

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

6.573B
Minimum
Jun 2020
14.26B
Maximum
Dec 2021
9.870B
Average
8.705B
Median
Jun 2021

Cash and Short Term Investments (Quarterly) Benchmarks

Novartis AG 9.694B
Pfizer Inc 12.69B
ADC Therapeutics SA 278.60M
Lonza Group Ltd 1.986B
AC Immune SA 122.68M